ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Direct to Consumer Genetic Testing Market to 2027 - ResearchAndMarkets.com

August 24, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Aug 24, 2021--

The “Global Direct to Consumer Testing Market to 2027” report has been added to ResearchAndMarkets.com’s offering.

Global Direct to Consumer Testing Market valued at USD 1.2 Billion in 2019 which is expected to grow at around 13% CAGR during 2020 to 2027.

Direct to consumer testing is manufactured by companies and directly provided to consumer without involvement of healthcare third party provider. Direct to consumer testing kits are affordable than genetic testing kits obtained through a healthcare provider. Direct to consumer testing market is expected to show significant growth during this forecast period due to rise in burden of various diseases like cancer and cardiovascular system diseases.

ADVERTISEMENT

In addition to that, increase in demand for ancestry DNA testing is expected to show growth of global direct to consumer testing market during this forecast period. Furthermore, increase in innovative launch in product development and rise in portfolio by various key competitors will have positive impact on global direct to consumer testing market.

Market Drivers

Increase in awareness about genetic testing among consumer is the key driving factor which is expected to boost the global direct to consumer market growth. Furthermore, rise in prevalence of genetic diseases such as cancer, cystic fibrosis is expected to propel the global direct to consumer testing market growth.

North America is expected to have significant growth in global direct to consumer testing market due to increase in prevalence of genetic diseases treatments and preventions. Europe has the second largest market share due to approval activities of test kits is expected to boost the global direct to consumer testing market. Also, Asia pacific will have the significant growth in global direct to consumer testing market over the forecast period.

Market Restraints

However, lack of awareness regarding genetic testing in undeveloped countries is major restraining factor which is expected to hamper the global direct to consumer testing market. Furthermore, Also, insecurities about genetic privacy will affect the global direct to consumer testing market growth.

Market Key Players

  • Shuwen Health Sciences
  • Canadian DNA Services
  • DNA Services of America
  • DNA Diagnostics Center
  • Sure Genomics
  • Walk-in-Lab
  • Alpha Biolaboratories
  • MapMyGenome
  • Positive Bioscience
  • Kailos Genetics
  • Gene by Gene
  • Genomics Express
  • DirectLabs
  • DNA4Life
  • 23andMe

 

ADVERTISEMENT

Key Topics Covered:

 

1. Executive Summary

1.1. Market Taxonomy

 

2. Global Direct to Consumer Testing Market Demand (in Value or Size in US$ Mn) Analysis and Forecast

 

3. Market Background

3.1. Forecast Factor

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Challenges

3.2.3. Trends

 

4. Global Direct to Consumer Testing Market Snapshot

 

5. Global Direct to Consumer Testing Market Analysis, By Type

5.1. Y-o-Y Growth Comparison, By Type

5.2. Global Direct to Consumer Testing Market Share Analysis, By Type

5.3. Global Direct to Consumer Testing Market Size and Forecast, By Type

5.3.1 Carrier Screening Test

5.3.2 Genetic Health Risk (GHR) Tests

5.3.3 Pharmacogenetics Tests

5.3.4 Cancer Predisposition Tests

5.3.5 Low Risk General Wellness Tests

5.3.6 Ancestry Tests

5.3.7 Paternity Testing

5.3.8 Cancer Susceptibility Tests

 

6. Global Direct to Consumer Testing Market Analysis, By Technology Type

6.1. Y-o-Y Growth Comparison, By Technology Type

6.2. Global Direct to Consumer Testing Market Share Analysis, By Technology Type

6.3. Global Direct to Consumer Testing Market Size and Forecast, By Technology Type

6.3.1 SNP-Chip genotyping

6.3.2 Whole genome sequencing

6.3.3 Next Generation Sequencing

6.3.4 Sanger Sequencing

 

7. Global Direct to Consumer Testing Market Analysis, By Sample Type

7.1. Y-o-Y Growth Comparison, By Sample Type

7.2. Global Direct to Consumer Testing Market Share Analysis, By Sample Type

7.3. Global Direct to Consumer Testing Market Size and Forecast, By Sample Type

7.3.1 Saliva Sample

7.3.2 Blood Sample

 

8. Global Direct to Consumer Testing Market Analysis, By Application

8.1. Y-o-Y Growth Comparison, By Application

8.2. Global Direct to Consumer Testing Market Share Analysis, By Application

8.3. Global Direct to Consumer Testing Market Size and Forecast, By Application

8.3.1 Cancer Diagnosis

8.3.2 Cardiovascular Disease Diagnosis

8.3.3 Genetic Disease Diagnosis

 

9. Global Direct to Consumer Testing Market Analysis, By Region

9.1. Y-o-Y Growth Comparison, By Region

9.2. Global Direct to Consumer Testing Market Share Analysis, By Region

 

10. North America Direct to Consumer Testing Market Analysis and Forecast (2017-2027)

 

11. Europe Direct to Consumer Testing Market Analysis and Forecast (2017-2027)

 

12. Asia Pacific Direct to Consumer Testing Market Analysis and Forecast (2017-2027)

 

13. Latin America Direct to Consumer Testing Market Analysis and Forecast (2017-2027)

 

14. Middle East & Africa Direct to Consumer Testing Market Analysis and Forecast (2017-2027)

 

15. Competition Analysis

15.1 Competition Dashboard

15.2 Market Share Analysis of Top Vendors

15.3 Key Development Strategies

 

16. Company Profiles

16.1 Overview

16.2 Offerings

16.3 Key Financial

16.4 Business Segment & Geographic Overview

16.5 Key Market Developments

16.6 Key Strategies

 

For more information about this report visit https://www.researchandmarkets.com/r/eo80l2.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210824005718/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES HOSPITALS GENETICS OTHER HEALTH GENERAL HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 08/24/2021 12:37 PM/DISC: 08/24/2021 12:37 PM

http://www.businesswire.com/news/home/20210824005718/en